Home
Conditions
Neuroendocrine Carcinoma

Clinical trial condition

Neuroendocrine Carcinoma

Explore clinical trials studying Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Carcinoma trial results

Recruiting

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

NCT02688894

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
Locations: Gachon University Gil Medical Center Incheon, South Korea

Seoul National University Bundang Hospital Seongnam, South Korea

Samsung Medical Center Seoul, South Korea

VHS Medical Center Seoul, South Korea

View Trial Details

Recruiting

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

NCT05747729

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

NCT06889493

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT05978284

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

NCT07038096

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Recruiting

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

NCT06333314

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
Locations: Institut de Cancérologie de l'Ouest Angers, France

Institut du Cancer Avignon-Provence Avignon, France

CHU Jean Minjoz Besançon, France

CHU Morvan Brest, France

View all 22 locations

View Trial Details

Recruiting

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

NCT04325425

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations: Chu de Caen Caen, France

Chu Dijon Bourgogne Dijon, France

Institut de Cancérologie de Bourgogne Dijon, France

Chu de Limoges - Dupuytren Limoges, France

View Trial Details

Recruiting

Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas

NCT04268121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
Locations: CHU Amiens - Hôpital Sud Amiens, France

CHU Jean Minjoz Besançon, France

Hôpital Beaujon Clichy, France

CHU Dijon Dijon, France

View all 14 locations

View Trial Details

Recruiting

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

NCT04464122

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations: Andrea M Isidori Rome, Italy

View Trial Details

Recruiting

Clinical Application of the J-PET Scanner Prototype

NCT06242119

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Department of Endocrinology and Nuclear Medicine, University Hospital in Krakow Krakow, Poland

View Trial Details

Neuroendocrine Carcinoma

Neuroendocrine Carcinoma trial results

Related conditions